World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
97
Citations
36986
World Ranking
816
National Ranking
459

Medicine

D-Index
97
Citations
36852
World Ranking
9238
National Ranking
4766

John J. Treanor publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John J. Treanor sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 299 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John J. Treanor D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John J. Treanor sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 97 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John J. Treanor is affiliated with the University of Rochester Medical Center in the United States. Their research primarily spans the field of medicine, with significant focus on epidemiology and infectious diseases. Additional subfields of study include genetics, oncology, and molecular biology.

The scientist's work addresses multiple topics, notably:

  • SARS-CoV-2 and COVID-19 research
  • Influenza virus research studies
  • Respiratory viral infections research
  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • COVID-19 clinical research studies
  • Protein structure and dynamics

John J. Treanor's recent publications focus largely on vaccine efficacy and immunological responses. Notable papers include:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S, 2022, New England Journal of Medicine
  • Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults, 2021, npj Vaccines
  • A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity, 2020, Viruses

These papers reflect work published in several key journals, including the New England Journal of Medicine, npj Vaccines, and Viruses.

Frequent collaborators in their research include Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas, and Georgi Shukarev. These coauthors have contributed alongside John J. Treanor in various studies and publications.

Best Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Influenza

    Unknown

  • Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

    John J. Treanor;Frederick G. Hayden;Peter S. Vrooman;Rick Barbarash

  • The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

    Robert B. Belshe;Paul M. Mendelman;John Treanor;James King

  • Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

    Abstr Act;Carlos A. DiazGranados;Andrew J. Dunning;Murray Kimmel

  • Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections

    Frederick G. Hayden;Albert D.M.E. Osterhaus;John J. Treanor;Douglas M. Fleming

  • Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

    John J. Treanor;James D. Campbell;Kenneth M. Zangwill;Thomas Rowe

  • Loneliness, Social Network Size, and Immune Response to Influenza Vaccination in College Freshmen.

    Sarah D. Pressman;Sheldon Cohen;Gregory E. Miller;Anita Barkin

  • Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

    F G Hayden;J J Treanor;R S Fritz;M Lobo

  • Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

    Seth J. Zost;Kaela Parkhouse;Megan E. Gumina;Kangchon Kim

  • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Iksung Cho

  • Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

    John J. Treanor;Bethanie E. Wilkinson;Feda Masseoud;Jean Hu-Primmer

  • Positive Emotional Style Predicts Resistance to Illness After Experimental Exposure to Rhinovirus or Influenza A Virus.

    Sheldon Cohen;Cuneyt M Alper;William J Doyle;John J Treanor

  • Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older

    Ann R. Falsey;John J. Treanor;Nadia Tornieporth;Jose Capellan

  • Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Harshvardhan B. Mehta

  • Efficacy of an acellular pertussis vaccine among adolescents and adults

    Joel I. Ward;James D. Cherry;Swei-Ju Chang;Susan Partridge

  • Serum antibody responses after intradermal vaccination against influenza.

    Robert B. Belshe;Frances K. Newman;Joan Cannon;Carol Duane

  • Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

    Yao Qing Chen;Teddy John Wohlbold;Nai Ying Zheng;Min Huang

  • Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans

    Matthew R Sandbulte;Gretchen S Jimenez;Adrianus C. M Boon;Larry R Smith

  • Objective and subjective socioeconomic status and susceptibility to the common cold.

    Sheldon Cohen;Cuneyt M. Alper;William J. Doyle;Nancy Adler

  • Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza

    Frederick G. Hayden;John J. Treanor;Robert F. Betts;Monica Lobo

  • Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

    John J Treanor;Karen Kotloff;Robert F Betts;Robert Belshe

  • Clinical responses to undiluted and diluted smallpox vaccine.

    Sharon E. Frey;Robert B. Couch;Carol O. Tacket;John J. Treanor

  • Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study

    Michael E Pichichero;Elsa Cernichiari;Joseph Lopreiato;John Treanor

Frequent Co-Authors

David J. Topham
David J. Topham University of Rochester Medical Center
Robert B. Belshe
Robert B. Belshe Saint Louis University
Michael E. Pichichero
Michael E. Pichichero Rochester Regional Health
Robert F. Betts
Robert F. Betts University of Rochester
Raphael Dolin
Raphael Dolin Beth Israel Deaconess Medical Center
Paul M. Mendelman
Paul M. Mendelman Takeda (Japan)
Frederick G. Hayden
Frederick G. Hayden University of Virginia
David I. Bernstein
David I. Bernstein University of Cincinnati
Kanta Subbarao
Kanta Subbarao University of Melbourne
Wendy A. Keitel
Wendy A. Keitel Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals transition into nursing or advanced practice roles, where a strong understanding of immunological principles is beneficial. If you're starting without a nursing background, exploring online ADN programs for non nurses offers a flexible pathway to enter the nursing field.

Additionally, accelerated pathways like accelerated BSN programs for non nurses provide an efficient route for those holding a bachelor’s degree in another discipline to quickly transition into nursing. For individuals aiming for practical nursing roles, accredited but accessible options such as accredited LPN programs easy to get into can help launch a career with less rigorous entry requirements.

Advanced practice roles like nurse practitioners also integrate well with immunology expertise. Prospective students can consider easiest NP programs to get into to pursue these high-impact positions that blend clinical skills with specialized immunological knowledge.

By leveraging these related online degree options, students and professionals can build a solid foundation that complements immunology studies and enhances career growth in healthcare.

Best Scientists Citing John J. Treanor

Trending Scientists

Recently Published Articles